AI Summary
This article discusses the development of a targeted drug delivery system for ovarian cancer therapy using an affibody-functionalized elastin-like peptide-drug conjugate nanomicelle. The nanomicelle is designed to specifically target cancer cells while minimizing side effects on healthy tissues. This innovative approach has the potential to improve the efficacy of ovarian cancer treatment and reduce adverse effects associated with current therapies.